SCHEMBL8632663

SCHEMBL8632663

COc1cc(F)ccc1-c1c[nH]nc1NS(=O)(=O)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 2/20 0.48
MAP2K4 P45985 1/20 0.45
CCNT1 O60563 4/20 0.45
CDK9 P50750 4/20 0.45
MAPK14 Q16539 1/20 0.44
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
SCN9A Q15858 4/20 0.43
PIK3CD O00329 1/20 0.43
PIK3CA P42336 1/20 0.43
PIK3CB P42338 1/20 0.43
PIK3CG P48736 1/20 0.43
AAK1 Q2M2I8 1/20 0.41
NR3C1 P04150 1/20 0.41
PGR P06401 1/20 0.41
NR3C2 P08235 1/20 0.41
AR P10275 1/20 0.41
CCNE1 P24864 1/20 0.41
CDK2 P24941 1/20 0.41
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8759199 0.92 CYP17A1 (0.45) CYP17A1MAP2K4CCNT1CDK9MAPK14
SCHEMBL8631496 0.86 MAPK14 (0.43) CYP17A1MAP2K4MAPK14KDM4EPIK3CD
SCHEMBL8629318 0.81 PTGS2 (0.50) MAPK14SCN9APIK3CAAAK1NR3C1
SCHEMBL8631178 0.79 STAT3 (0.47) MAP2K4MAPK14KDM4ELMNAMAPT
SCHEMBL8630531 0.79 MAPT (0.45) CYP17A1MAP2K4CCNT1CDK9MAPK14
SCHEMBL8629484 0.79 MAP2K4 (0.45) MAP2K4MAPK14PIK3CDPIK3CAPIK3CB
SCHEMBL8631045 0.78 STAT3 (0.42) CYP17A1MAP2K4MAPK14KDM4EALDH1A1
SCHEMBL8759075 0.78 MCL1 (0.41) MAP2K4MAPK14ALDH1A1PIK3CA
SCHEMBL8629394 0.78 KDM4E (0.40) MAPK14KDM4ELMNAMAPT
SCHEMBL8627771 0.77 ALDH1A1 (0.47) CYP17A1KDM4EALDH1A1PIK3CAAAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5756530-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G. D. SEARLE & CO. (US) 1998-05-26 US disclosed